Literature DB >> 1085285

Synergy between human T and B lymphocytes in their response to phythaemagglutinin and pokeweed mitogen.

M E Weksler, M M Kuntz.   

Abstract

Human B- and T-lymphocyte preparations were isolated by separating T lymphocytes that formed rosettes with sheep erythrocytes from unrosetted B lymphocytes. Pokeweed mitogen stimulates the proliferation of both B- and T-lymphocyte preparations. In contrast, phytohaemagglutinin stimulates little or no proliferation of purified B lymphocytes although it stimulates the proliferation of T lymphocytes. Lymphoid preparations containing both T and B lymphocytes are more responsive to both mitogens than are either T- or B-lymphocyte preparations. This observation suggested synergy between T and B lymphocytes in the response of unfractionated lymphocytes to mitogens. The basis for this synergy was shown to be the capacity of T lymphocytes to facilitate the proliferation of B lymphocytes cultured with pokeweed mitogen or phytohaemagglutinin. The activity of T lymphocytes is not dependent upon their proliferation or attributable to their release of mitogenic factors. With regard to the clinical evaluation of immune function, our results indicate that the proliferative response of human lymphocytes to phytohaemagglutinin or pokeweed mitogen cannot be directly related to the percentage of T lymphocytes in the lymphoid preparation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085285      PMCID: PMC1445115     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Response of human thymus-derived (T) and non-thymus-derived (B) lymphocytes to mitogenic stimulation in vitro.

Authors:  R S Geha; E Merler
Journal:  Eur J Immunol       Date:  1974-03       Impact factor: 5.532

2.  Unresponsiveness of human B lymphocytes to phytohaemagglutinin.

Authors:  R S Geha; F S Rosen; E Merler
Journal:  Nature       Date:  1974-03-29       Impact factor: 49.962

3.  Induction of lymphokine production by EAC and of blastogenesis by soluble mitogens during human B-cell activation.

Authors:  B F Mackler; L C Altman; D L Rosenstreich; J J Oppenheim
Journal:  Nature       Date:  1974-06-28       Impact factor: 49.962

4.  The mitogenic response of human B lymphocytes to phytohaemagglutinin.

Authors:  B Phillips; E Weisrose
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

5.  Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens.

Authors:  L B Epstein; H W Kreth; L A Herzenberg
Journal:  Cell Immunol       Date:  1974-06       Impact factor: 4.868

6.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

7.  Letter: Lymphocyte response.

Authors:  M E Weksler; M E Kuntz; M Lockshin; R Kohn; A C Eisenhauer
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

8.  Evidence for transformation of human B lymphocytes by PHA.

Authors:  B Phillips; I M Roitt
Journal:  Nat New Biol       Date:  1973-02-21

Review 9.  Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens.

Authors:  M Greaves; G Janossy; M Doenhoff
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

10.  Cellular interactions in the proliferative response of human T and B lymphocytes to phytomitogens and allogeneic lymphocytes.

Authors:  H P Lohrmann; L Novikovs; R G Graw
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  17 in total

1.  Effects of natural eggshell membrane (NEM) on cytokine production in cultures of peripheral blood mononuclear cells: increased suppression of tumor necrosis factor-α levels after in vitro digestion.

Authors:  Kathleen F Benson; Kevin J Ruff; Gitte S Jensen
Journal:  J Med Food       Date:  2011-12-14       Impact factor: 2.786

2.  Expression of low-density lipoprotein receptors in peripheral blood and tonsil B lymphocytes.

Authors:  J B De Sanctis; I Blanca; H Rivera; N E Bianco
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  T-lymphocyte dependency of B-lymphocyte blastogenic response to phytomitogens.

Authors:  T Han; B Dadey
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

4.  Activation of human lymphocyte subpopulations by protein A from Staphylococcus aureus bacteria.

Authors:  W Vogt; A Willberg; G Bochert; G Sieber; H Rühl
Journal:  Blut       Date:  1979-10

5.  [Intercellular contacts in chronic rhinosinusitis and their possible significance. A light and electron microscopic investigation (author's transl)].

Authors:  K W Albegger; G P Tilz
Journal:  Arch Otorhinolaryngol       Date:  1977-05-31

6.  Activation of human B lymphocytes induced by Robinia pseudoacacia lectin in the presence of T cells.

Authors:  A Sharif; J Brochier; Y Goussault; R Bourrillon
Journal:  Immunology       Date:  1978-10       Impact factor: 7.397

7.  Different mitogenic activity of soluble and insoluble staphylococcal protein A (SPA).

Authors:  S Romagnani; A Amadori; M G Giudizi; R Biagiotti; E Maggi; M Ricci
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

8.  Kinetics of mitogen-induced proliferation and differentiation of human peripheral blood B lymphocytes.

Authors:  T V Shankey; R P Daniele; P C Nowell
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

9.  Response of sensitized and unsensitized human lymphocyte subpopulations to Plasmodium falciparum antigens.

Authors:  D J Wyler; H G Herrod; F I Weinbaum
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

10.  Stimulation of canine lymphocyte subpopulations separated nonlytically by monoclonal anti-T and polyclonal anti-B cell antibodies.

Authors:  J C Wulff; M S Tsoi; J Aprile; H J Deeg; N Durkopp; R Storb
Journal:  Blut       Date:  1982-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.